Drugs / KT07
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05223660 | Jan → Jul 2022 | — | Yiling Pharmaceutical Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02867358 Comparator | Sep 2016 → Jul 2020 | influenza | Yiling Pharmaceutical Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KT07 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02867358 ↗ |
| Route | Oral | “following an oral administration of KT07” NCT05223660 ↗ |